Cognova Lifescience

Ahmedabad, India
Provides comprehensive therapeutic solutions for pediatric care.

About Cognova Lifescience

Cognova Lifescience is a Healthcare company based in Ahmedabad (India) by Dhaval Patel. It provides comprehensive therapeutic solutions for pediatric care. It operates on a B2B model. Its Indian entity Cognova Lifescience Private Limited reported revenue of β‚Ή82.7 Lakh. Its focus areas include Pharmaceuticals, Therapeutics and Pediatric Care. Its competitors include Ironwood Pharma, VeraDermics, Lipum, Proveca and Castle Creek Biosciences and 5 more; 8 of its 10 listed competitors have raised funding.

Company details

Cognova Lifescience provides comprehensive therapeutic solutions for pediatric care, focusing on providing healthcare solutions, producing pharmaceutical products, therapeutics, and pediatric care. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

  • Headquarters Ahmedabad, India
  • Founders Dhaval Patel
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cognovalifescience.com
  • Legal Name Cognova Lifescience Private Limited
  • Date of Incorporation 02 Apr, 2019
  • Jurisdiction Ahmedabad, Gujarat, India
Operational Areas
Key Metrics
  • Annual Revenue
    ₹82.7 Lakh

    FY 2024 · -5% YoY

  • Net Loss
    -₹1.2 Lakh

    FY 2024 · -1% margin

  • EBITDA
    ₹73,256

    FY 2024 · 1% margin

Board of directors of Cognova Lifescience Private Limited (Cognova Lifescience)

Cognova Lifescience Private Limited is the primary company behind Cognova Lifescience. The board of Cognova Lifescience Private Limited currently have 2 directors; the longest-serving is Dhavalkumar Pravinbhai Patel, appointed in 2019. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Dhavalkumar Pravinbhai Patel
DIN 08410656
Director02 Apr 20197 yrs 6 moCognova Lifescience Private Limited
Vivek Joshi
DIN 08410658
Director02 Apr 20197 yrs 6 moCognova Lifescience Private Limited

People of Cognova Lifescience

1 people are tracked at Cognova Lifescience (1 in leadership).

NameRoleGroup
Dhaval Patel
FounderLeadership
Premium access

Complete people profiles for Cognova Lifescience

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Cognova Lifescience

Figures of Cognova Lifescience Private Limited, the primary company behind Cognova Lifescience, for FY 2024. Revenue was ₹82.7 Lakh (-5% year on year). Net loss was -₹1.2 Lakh (-1% margin). EBITDA was ₹73,256 (1% margin). Revenue has grown at a compounded annual rate of +44% over three years.

  • ₹82.7 LakhRevenue · FY 2024 · -5% YoY
  • -₹1.2 LakhNet loss · -1% margin
  • ₹73,256EBITDA · 1% margin
  • ₹1 LakhPaid-up capital
  • +44%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Cognova Lifescience Private Limited are on its company page.

Premium access

Detailed financial statements for Cognova Lifescience

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Cognova Lifescience

Cognova Lifescience has 10 listed competitors in our database, 8 of them funded. They include Ironwood Pharma, VeraDermics, Lipum, Proveca and Castle Creek Biosciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
ironwoodpharma.com1998Cambridge, United States$206.25M220
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
veradermics.com2020San Antonio, United States$262.71M–
Drug-delivery platforms for pediatric wart treatments are developed.
lipum.se2010Umea, Sweden$2.99M–
Developer of antibody to treat juvenile idiopathic arthritis
proveca.com2010Manchester, United Kingdom$8.45M23
Medicines for chronic diseases in children are developed and provided.
castlecreekbio.com2018Exton, United States$192.8M41
Gene therapy platform for rare disease treatments is developed.
orphelia-pharma.eu2007Paris, France$4.49M–
Therapies for pediatric neurology, oncology, and hematology are developed.
visenpharma.com2018Shanghai, China$150M3
Therapeutics for endocrine diseases are developed using TransCon technology.
oncoheroes.com2017Brookline, United States$9.95M–
Therapies for pediatric cancer in children are discovered and developed.
gate2brain.com2019Barcelona, Spain––
Therapeutics delivery platform across biological barriers is developed.
allievex.com2017Marblehead, United States–7
Developer of therapeutics for rare neurodegenrative diseases
Premium access

Detailed competitors of Cognova Lifescience

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Pediatrics

10 companies that operate in the same segment as Cognova Lifescience (Pediatrics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Owlet is recognized for developing FDA-cleared smart baby monitors.
2013Lehi, Utah, United StatesUSD 54.96 MUSD 105.71 M85
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
1998Cambridge, Massachusetts, United StatesUSD 206.25 MUSD 296.15 M253
Smart baby monitors and sleep tracking solutions are provided.
2014New York, New York, United StatesUSD 116.6 M––
Provider of diagnostic products for pediatrics
2013Durham, North Carolina, United StatesUSD 95.89 M––
Eye-tracking solutions for vision assessment and treatment are provided.
2016Lod, Central District, IsraelUSD 8 M––
Patient vital signs are monitored via wearable devices and software.
2018Niles, Illinois, United StatesUSD 71 M––
Pediatric orthopedic devices are developed for surgical applications.
2006Warsaw, United StatesUSD 51.55 MUSD 236.35 M562
Gene therapy platform for rare disease treatments is developed.
2018Exton, Pennsylvania, United StatesUSD 192.8 M–41
Pediatric cardiac surgical devices are developed for congenital heart defects.
2011Pittsburgh, Pennsylvania, United StatesUSD 22.56 M––
Drug-delivery platforms for pediatric wart treatments are developed.
2020San Antonio, Texas, United StatesUSD 262.71 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Cognova Lifescience

Cognova Lifescience is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

The primary company behind Cognova Lifescience, Cognova Lifescience Private Limited, reported revenue of β‚Ή82.7 Lakh for FY 2024, down 5% year on year.

Cognova Lifescience provides comprehensive therapeutic solutions for pediatric care, focusing on providing healthcare solutions, producing pharmaceutical products, therapeutics, and pediatric care. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets. It continues to evolve, meeting industry challenges with strategic approaches.

Cognova Lifescience's top competitors include Ironwood Pharma, Castle Creek Biosciences and VeraDermics.

Cognova Lifescience operates through Cognova Lifescience Private Limited.

The legal entities of Cognova Lifescience currently have 2 directors, including Dhavalkumar Pravinbhai Patel, Vivek Joshi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available